FirsthandHealth
medRxiv PreprintsInternational20 November 2026

Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Slow-wave sleep (SWS) has been implicated in memory consolidation and brain plasticity and proposed as a therapeutic target in major depressive disorder (MDD). However, whether pharmacological promotion of SWS causally improves memory consolidation remains unknown. Gamma-hydroxybutyrate (GHB), a robust enhancer of SWS, represents a promising drug-repurposing candidate to target this pathway. We therefore conducted a randomized, double-blind, placebo-controlled crossover trial in 22 patients with MDD and 20 matched healthy controls receiving single nocturnal doses of GHB, trazodone as an active
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.